Our clients are diverse, based in and outside the U.S., ranging from early-stage startups to NASDAQ and NYSE-traded multinational firms. We concentrate on providing practical solutions and pride ourselves on being nimble and responsive in helping clients anticipate and overcome challenges and capitalize on opportunities.
We routinely represent clients before the U.S. Food and Drug Administration and the other federal and state regulatory bodies. We counsel clients on issues relating to product development and approval, clinical trials, labeling and advertising, product lifecycle management, regulatory due diligence, compliance and inspections, to name a few. We often collaborate with other AGG professionals whose expertise extends our capabilities even further, including attorneys from corporate, intellectual property, healthcare, government investigations, and logistics and transportation. This multidisciplinary approach has enabled us to become our clients’ trusted partner, because we are able to address the highly complex legal issues they face in the context of their unique business needs.
To learn more about our sub-practices, please proceed to our dedicated pages listed below.
We currently serve as General Counsel to the Sharing Alliance, Inc. (formerly known as the PDMA Alliance, Inc.), and our attorneys are founding members (and are Board members) of GeorgiaBio (Georgia’s Life Science trade association). They have taught food and drug law at Emory University School of Law and lectured at programs sponsored by the Food and Drug Law Institute and the Regulatory Affairs Professionals Society. Our attorneys also serve on the editorial boards of a number of national FDA and regulatory periodicals, and sit on the Board of the National Health Museum. We are also recognized by leading rankings institutions including Chambers, USA, Who’s Who Legal (Life Sciences) and Best Lawyers.